PATENT CLAIM ANALYSIS

Application Number: 16210968
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.

Claim (Index 4):
The composition of  claim 2  wherein the co-therapeutic agent is a B-RAF inhibitor or a C-Raf inhibitor.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14527328', '14428546', '12812360', '11832208', '15672568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7847238081287246
- 35 USC 102 Novelty (BERT): 0.5562611871439997
- Combined Prediction Score: 0.761877546030252
- Mean Citation Score: 359.713364
- Max Citation Score: 444.24866
- Similarity Product: 263.9220379929089

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test